What is the recommended dosing regimen for L‑methylfolate?

L-Methylfolate Dosing Recommendations

For most clinical applications, L-methylfolate is dosed at 7.5-15 mg daily, with 15 mg/day demonstrating superior efficacy in psychiatric conditions, while standard folic acid supplementation ranges from 0.4-5 mg daily depending on the indication.

Context: L-Methylfolate vs. Folic Acid

It's critical to distinguish between L-methylfolate (the bioactive form) and folic acid (the synthetic precursor), as the evidence base and dosing differ substantially:

• L-methylfolate bypasses metabolic conversion steps and is used primarily in psychiatric conditions and specialized medical applications 1
• Folic acid requires enzymatic conversion and is the standard form for deficiency treatment and prevention 2

L-Methylfolate Dosing (Active Form)

Standard Adult Dosing

• Typical dose: 7.5-15 mg daily orally 1
• The FDA-approved formulation recommends 1-2 tablets daily as directed by a medical practitioner 1
• Not recommended for children under 12 years 1

Psychiatric Applications

• 15 mg/day is significantly more effective than 7.5 mg/day for SSRI-resistant major depressive disorder 3
• The 15 mg dose showed superior response rates with a number needed to treat of approximately 6 3
• Well-tolerated in adolescents and children (ages 7-20) at 15 mg/day, with adverse events occurring in only 10% of patients 4
• Biomarkers (BMI ≥30 kg/m², elevated inflammatory markers) may predict better response to 15 mg dosing 5

Safety Considerations

• Must include vitamin B12 supplementation (1 mg cyanocobalamin) to prevent masking pernicious anemia when folate doses exceed 0.1 mg daily 1
• Pyridoxine sources should be monitored, with a safe upper limit of 100 mg/day 1
• L-methylfolate was well-tolerated across studies with adverse event rates similar to placebo 3, 4

Folic Acid Dosing (Standard Form)

Deficiency Treatment

• 5 mg daily orally for minimum 4 months until deficiency is corrected 2
• Always exclude vitamin B12 deficiency first before initiating folic acid to prevent subacute combined degeneration of the spinal cord 2
• Maintenance after treatment: 330 mcg DFE for adults, 600 mcg DFE for pregnant/lactating women 2

Special Populations

Hemodialysis patients with hyperhomocysteinemia:

• Non-diabetic: 5 mg or more daily 2
• Diabetic: 15 mg daily 2

Neural tube defect prevention:

• 0.4 mg (400 mcg) daily for all women of childbearing age periconceptionally 2
• Should be taken continuously while capable of becoming pregnant, as >50% of pregnancies are unplanned 2
• 4 mg daily for women with prior NTD-affected pregnancy when planning conception 2

Methotrexate therapy:

• 5 mg weekly to 5 mg daily to reduce mucosal, gastrointestinal, and hepatotoxic side effects 2
• Avoid taking on the same day as methotrexate due to potential competitive cellular uptake 2

Parenteral Administration

• 0.1 mg/day subcutaneously, IV, or IM when oral treatment is ineffective or not tolerated 2

Critical Safety Warnings

Vitamin B12 Masking Risk

• Never give folic acid before excluding B12 deficiency 2
• Folic acid can improve hematologic parameters while neurological damage progresses in undiagnosed B12 deficiency 2
• The upper limit of 1 mg/day for unsupervised folic acid use was established specifically to minimize this risk 2

Maximum Safe Doses

• Upper limit: 1 mg/day for general folic acid supplementation to avoid masking B12 deficiency 2
• Total daily folate consumption should remain <1 mg/day unless medically supervised 2
• The LOAE (Lowest Observed Adverse Effect) is set at 5 mg/day 2

Monitoring

• Measure folate status at baseline and repeat within 3 months after supplementation to verify normalization 2
• In conditions with increased folate needs, measure every 3 months until stabilization, then annually 2
• Serum folate should be ≥10 nmol/L and RBC folate ≥340 nmol/L 2